Mochida Pharmaceutical Co Ltd
MFY
Company Profile
Business description
Mochida Pharmaceutical Co Ltd is a major drug manufacturing company that operates in the field of medical care through its pharmaceuticals, healthcare products, and medical equipment businesses. The company's pharmaceuticals business aims to develop and market a broad spectrum of innovative new drugs. One of Mochida's main objectives is to maximize the business performance of its drugs after they are developed and released. The company also creates skin care products for the general public, and these are supplied through pharmacies, drugstores, and mail-order sales.
Contact
1-1 Ichigayahonmuracho
Shinjuku-ku
Tokyo162-0845
JPNT: +81 333587211
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 March 2025
Employees
2,017
Stocks News & Analysis
stocks
ASX shares plunge but remain undervalued
Shares drop 17% after guidance is revised but we still see value.
stocks
Ask the analyst: Why have markets shunned APA Group?
Australia's premier gas infrastructure firm used to be a market darling, but its shares have taken a severe de-rating in recent years.
stocks
The 10 best US dividend stocks
These undervalued stocks with reliable dividends are worth considering.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,473.70 | 41.80 | 0.50% |
| CAC 40 | 7,408.64 | 22.40 | -0.30% |
| DAX 40 | 20,132.85 | 81.94 | -0.41% |
| Dow JONES (US) | 42,297.12 | 358.67 | 0.86% |
| FTSE 100 | 8,224.19 | 24.30 | -0.29% |
| HKSE | 18,874.14 | 190.15 | -1.00% |
| NASDAQ | 19,088.10 | 73.53 | -0.38% |
| Nikkei 225 | 39,012.34 | 178.06 | -0.45% |
| NZX 50 Index | 12,865.35 | 38.02 | 0.30% |
| S&P 500 | 5,836.22 | 9.18 | 0.16% |
| S&P/ASX 200 | 8,232.60 | 40.70 | 0.50% |
| SSE Composite Index | 3,160.75 | 7.77 | -0.25% |